Status:
UNKNOWN
Treatment of Acute Stroke With Cromolyn(Single Dose)
Lead Sponsor:
Wolfson Medical Center
Conditions:
Acute Stroke
Eligibility:
All Genders
20-90 years
Phase:
PHASE3
Brief Summary
Mastocytes were proven to have a central rule in their development of the lipoid plaque of the vascular system. Mastocytes also has an important role in the stabilisation of the plaque in the building...
Eligibility Criteria
Inclusion
- Infarction of the anterior Circulation system.
- Both genders
- Age \> 20 years
- NIHSS \> 5 -
Exclusion
- Non- ischaemic stroke
- Additional disease of the CNS
- Known allergy to cromolyn
- Diseae of mastocytosis
- Renal or Hepatic failure (acute or chronic)
- Inability to sign consent form (dementia or sensory aphasia)
- Lacunar infarctions
- INfarction present in cerebellum or brain stem -
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01175525
Last Update
August 5 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edith wolfson medical Center
Holon, Israel, 58100